ICAM1 and prostate carcinoma: In addition to the growth and progression of prostate cancer itself, research has been proposed that exosome PSGR1 might regulate MAPK and NF-κB signaling pathways involved in prostate cancer bone metastasis by targeting ICAM1, RELB, and IL1B (Li et al., 2020).